Clinical Trial Update: Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection

View source ↗

Summary

Aztreonam lysine for inhalation has been approved for use in patients with cystic fibrosis who have Pseudomonas aeruginosa airway infection. The product is mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Airway Infection

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis, Pseudomonas Aeruginosa Airway Infection | Status: APPROVED_FOR_MARKETING